Recent Posts
A “Money Blind” for Research into Maternal-Fetal Medication Risk?
By Kate Greenwood Cross-Posted at Bill of Health A week ago, the Food and Drug Administration announced the results of a review of the medical literature it conducted in response to “recent reports questioning the safety of prescription and over-the-counter (OTC) pain medicines when used during pregnancy.” The literature, FDA determined, is inconclusive. FDA found […]
Upcoming SHU Law Networking Event
For those in the area, Seton Hall Law’s Center for Health & Pharmaceutical Law & Policy is sponsoring what looks to be a great event next Thursday, January 22nd, celebrating the diversity of the compliance profession.
Monday Morning Recap: The Previous Week (1.5.15-1.11.15) in Drug & Device Law & Policy
Happy New Year! After a break (during which, you may have noticed, Health Reform Watch has been undergoing a thorough update), we’re back with the Monday Morning Recap, the post where we call out recent drug and device law and policy developments that caught our eye and made us think. We hope you find this […]
Politics, Law and the Real World: Reconciling the Disconnect Among the Supreme Court, Voters, and Public Health
By Nina Trovato In the landmark 2012 decision, National Federation of Independent Business v. Sebelius, Chief Justice Roberts, writing for the majority, struck the Affordable Care Act’s Medicaid expansion because its funding conditions for states’ participation were unconstitutionally coercive. As a result, states now choose whether or not they will accept the Medicaid expansion funding. […]
The ‘Halbig Cases’: Partisan Interpretation? Time Will Tell
By Brandon Zarsky A string of recent cases across the country has dealt what many consider a heavy blow to the Obama Administration’s Patient Protection and Affordable Care Act (Obamacare). However, some of the effects of these holdings could prove to be short-lived. The text of the ACA provides tax credits and cost-sharing subsidies for […]
Recent Comments